Suppr超能文献

阿尔茨海默病中性别特异性差异的生物学和临床意义。

Biological and Clinical Implications of Sex-Specific Differences in Alzheimer's Disease.

机构信息

NeuroHub Analytics, LLC, Chicago, IL, USA.

Cellular and Molecular Pharmacology Department, Center for Neurodegenerative Diseases and Therapeutics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

出版信息

Handb Exp Pharmacol. 2023;282:181-197. doi: 10.1007/164_2023_672.

Abstract

Mounting evidence indicates that the female sex is a risk factor for Alzheimer's disease (AD), the most common cause of dementia worldwide. Decades of research suggest that sex-specific differences in genetics, environmental factors, hormones, comorbidities, and brain structure and function may contribute to AD development. However, although significant progress has been made in uncovering specific genetic factors and biological pathways, the precise mechanisms underlying sex-biased differences are not fully characterized. Here, we review several lines of evidence, including epidemiological, clinical, and molecular studies addressing sex differences in AD. In addition, we discuss the challenges and future directions in advancing personalized treatments for AD.

摘要

越来越多的证据表明,女性是阿尔茨海默病(AD)的一个风险因素,AD 是全球最常见的痴呆症病因。几十年来的研究表明,遗传、环境因素、激素、合并症以及大脑结构和功能方面的性别特异性差异可能导致 AD 的发生。然而,尽管在揭示特定遗传因素和生物学途径方面取得了重大进展,但性别差异背后的确切机制仍未完全阐明。在这里,我们回顾了一些证据,包括针对 AD 中性别差异的流行病学、临床和分子研究。此外,我们还讨论了在推进 AD 的个性化治疗方面面临的挑战和未来方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验